Mathematical model for determining the binding constants between immunoglobulins, bivalent ligands, and monovalent ligands-Reference-Cited by-同舟云学术

Mathematical model for determining the binding constants between immunoglobulins, bivalent ligands, and monovalent ligands

Published:2010-12-16 Issue:4 Volume:399 Page:1641-1652
ISSN:1618-2642
Container-title:Analytical and Bioanalytical Chemistry
language:en
Short-container-title:Anal Bioanal Chem

Author:

Mack Eric T.,Cummings Linda,Perez-Castillejos Raquel

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry,Analytical Chemistry

Link

http://link.springer.com/content/pdf/10.1007/s00216-010-4477-y.pdf

Reference22 articles.

1. Murphy K, Travers P, Walport M (2008) Janeway’s immunobiology, 7th edn. Garland Science, New York

2. Davies DR, Metzger H (1983) Structural basis of immunology. Annu Rev Immunol 1:87–117

3. Dembo M, Goldstein B (1978) Theory of equilibrium binding of symmetric bivalent haptens to cell surface antibody: application to histamine release from basophils. J Immunol 121:345–353

4. Goldstein B, Wofsy C (1980) Theory of equilibrium binding of a bivalent ligand to cell surface antibody: the effect of antibody heterogeneity on cross-linking. J Math Biol 10:347–366

5. Wofsy C (1980) Analysis of a molecular signal for cell function in allergic reactions. Math Biosci 40:69–86

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Divalent ligand-monovalent molecule binding;2021-01-14

2. Divalent ligand-monovalent molecule binding;Soft Matter;2021

3. Biophysical Considerations for Development of Antibody-Based Therapeutics;Development of Antibody-Based Therapeutics;2018

4. Considerations for Construct and Affinity Design Goals;Development of Antibody-Based Therapeutics;2018

5. A general model for predicting the binding affinity of reversibly and irreversibly dimerized ligands;PLOS ONE;2017-11-22